James D. Rodgers

Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms

Alfonso Quintás‐Cardama, Kris Vaddi, Phillip Liu et al. · Blood · 2010 · 813 citations

Selective Inhibition of JAK1 and JAK2 Is Efficacious in Rodent Models of Arthritis: Preclinical Characterization of INCB028050

Jordan S. Fridman, Peggy Scherle, Robert J. Collins et al. · The Journal of Immunology · 2010 · 440 citations · Full text

Immunology, Kinase Inhibitors, Immunotherapy +21

Electrochemical Oxidation of Chlorinated Phenols

James D. Rodgers, Wojciech Jȩdral, Nigel J. Bunce · Environmental Science & Technology · 1999 · 322 citations

Environmental Electrochemistry, Chemical Engineering, Engineering +10

Inhibition of Clinically Relevant Mutant Variants of HIV-1 by Quinazolinone Non-Nucleoside Reverse Transcriptase Inhibitors

Jeffrey W. Corbett, Soo S. Ko, James D. Rodgers et al. · Journal of Medicinal Chemistry · 2000 · 299 citations · Full text

Enantioselective Synthesis of Janus Kinase Inhibitor INCB018424 via an Organocatalytic Aza-Michael Reaction

Qiyan Lin, David Meloni, Yongchun Pan et al. · Organic Letters · 2009 · 167 citations

Engineering, Organic Chemistry, Chemistry +16